Publicaciones en colaboración con investigadores/as de Pitié-Salpêtrière Hospital (86)

2024

  1. A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

    Alzheimer's Research and Therapy, Vol. 16, Núm. 1

  2. Diagnostic accuracy of research criteria for prodromal frontotemporal dementia

    Alzheimer's Research and Therapy, Vol. 16, Núm. 1

  3. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

  4. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results

    Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542

  5. NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study

    Journal of Neurology, Neurosurgery and Psychiatry

  6. Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease

    Brain : a journal of neurology, Vol. 147, Núm. 5, pp. 1887-1898

  7. Serum Neurofilament Light Chain in Replication Factor Complex Subunit 1 CANVAS and Disease Spectrum

    Movement Disorders, Vol. 39, Núm. 1, pp. 209-214

2023

  1. Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 30, pp. 4768-4778

  2. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

    Human Brain Mapping, Vol. 44, Núm. 7, pp. 2684-2700

  3. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

    Neurobiology of Disease, Vol. 179

  4. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

    Movement Disorders, Vol. 38, Núm. 2, pp. 286-303

  5. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  6. Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: Comparison with sporadic primary progressive aphasia

    Brain Communications, Vol. 5, Núm. 2

  7. Language impairment in the genetic forms of behavioural variant frontotemporal dementia

    Journal of Neurology, Vol. 270, Núm. 4, pp. 1976-1988

  8. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1573-1586

  9. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1466-1477

  10. Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers

    Brain : a journal of neurology, Vol. 146, Núm. 5, pp. 2120-2131

  11. Neuropsychiatric symptoms in genetic frontotemporal dementia: Developing a new module for Clinical Rating Scales

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, Núm. 5, pp. 357-368

  12. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

    Journal of the Neurological Sciences, Vol. 451

  13. Psychological Distress in a Sample of Adult Italian Patients Affected by Vocal Nodules and Muscle-Tension Dysphonia: Preliminary Results

    Journal of Voice, Vol. 37, Núm. 2, pp. 300.e21-300.e29